Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Preparation of a Codelivery System Based on Vancomycin/Silk Scaffold Containing Silk Nanoparticle Loaded Vegf Publisher Pubmed



Hassani Besheli N1 ; Damoogh S2 ; Zafar B3 ; Mottaghitalab F4 ; Motasadizadeh H5 ; Rezaei F6 ; Shokrgozar MA2 ; Farokhi M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Chemical Engineering, Collage of Engineering, University of Tehran, P.O. Box 11155-4563, Tehran, 1417466191, Iran
  2. 2. National Cell Bank of Iran, Pasteur Institute of Iran, P.O. Box 1316943551, Tehran, 1316943551, Iran
  3. 3. Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, 14177-55469, Iran
  4. 4. Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran, 1417613151, Iran
  5. 5. Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 1417614411, Iran
  6. 6. Faculty of Biomedical Engineering, Amirkabir University of Technology, Tehran, 15875/4413, Iran

Source: ACS Biomaterials Science and Engineering Published:2018


Abstract

One of the main challenges of using biomaterials for inducing bone regeneration is the bacterial resistance before complete bone repair. Biomaterials with both antibacterial and bone regeneration properties are more promising for bone repair. In the present study, vascular endothelial growth factor (VEGF) was loaded on silk fibroin nanoparticles (SFNPs) and then embedded in silk scaffold containing vancomycin to form a dual drug release system. The chemical and physical properties of the fabricated structure were confirmed by Fourier transform infrared, scanning electron microscopy, and potential analysis. The size of spherical SFNPs was a92 nm. The release kinetics of vancomycin and VEGF showed that a99.56% of vancomycin and a14% of VEGF were released during 21 and 28 days, respectively. The bioactivity of VEGF was a75%. Disk diffusion test confirmed the ability of this drug delivery system against methicillin-resistant Staphylococcus aureus (MRSA). Moreover, expression of the endothelial markers (FLK-1, VWF, and VE-cadherin), alkaline phosphatase, and matrix mineral production were higher in VEGF loaded groups. Taken together, the results indicated that the fabricated codelivery system was able to simultaneously deliver antibiotic and angiogenic factor, which can be considered as a potential candidate for the treatment of contaminated bone injuries. © 2018 American Chemical Society.
Other Related Docs
10. Recent Trends in Controlled Drug Delivery Based on Silk Platforms, Silk-Based Biomaterials for Tissue Engineering# Regenerative# and Precision Medicine# 2nd Edition (2023)
12. Prospects of Sirna Applications in Regenerative Medicine, International Journal of Pharmaceutics (2017)
13. Silk As a Potential Candidate for Bone Tissue Engineering, Journal of Controlled Release (2015)
16. Overview of Silk Fibroin Use in Wound Dressings, Trends in Biotechnology (2018)
22. Thermo-Sensitive Polymers in Medicine: A Review, European Polymer Journal (2019)